2. Academic Validation
  3. Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation

  • Oncoimmunology. 2022 Jul 1;11(1):2093054. doi: 10.1080/2162402X.2022.2093054.
Teng He 1,  Zhixing Hao 2 3,  Mingjie Lin 2 3,  Zhongwei Xin 2 3,  Yongyuan Chen 2 3,  Wei Ouyang 1,  Qi Yang 4,  Xiaoke Chen 2 3,  Hui Zhou 1,  Wanying Zhang 1,  Pin Wu 2 3,  Feng Xu 1
Affiliations

Affiliations

  • 1 Department of Infectious Diseases, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • 2 Department of Thoracic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • 3 Key Laboratory of Tumor Microenvironment and Immune Therapy of Zhejiang Province, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • 4 Department of Emergency, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
PMID: 35800155 DOI: 10.1080/2162402X.2022.2093054
Abstract

Inducing a full antitumor immune response in the tumor microenvironment (TME) is essential for successful Cancer Immunotherapy. Here, we report that an oncolytic adenovirus carrying mIL-15 (Ad-IL15) can effectively induce antitumor immune response and inhibit tumor growth in a mouse model of Cancer. We found that Ad-IL15 facilitated the activation and infiltration of immune cells, including dendritic cells (DCs), T cells and natural killer (NK) cells, in the TME. Unexpectedly, we observed that Ad-IL15 also induced vascular normalization and tertiary lymphoid structure formation in the TME. Moreover, we demonstrated these Ad-IL15-induced changes in the TME were depended on the Ad-IL15-induced activation of the STING-TBK1-IRF3 pathway in DCs. Taken together, our findings suggest that Ad-IL15 is a candidate for Cancer Immunotherapy that promotes immune cell activation and infiltration, tumor vascular normalization and tertiary lymphoid structure formation in the TME.

Keywords

DC; Oncolytic virus; STING; tertiary lymphoid structure; vascular normalization.

Figures
Products